Circulating Levels of Visfatin/Pre-B-Cell Colony-Enhancing Factor 1 in Relation to Genotype, GFR, Body Composition, and Survival in Patients With CKD

American Journal of Kidney Diseases

Volumn 49, Issue 2, 2007, Pages 237-244

  Axelsson, Jonas ^a   Witasp, Anna ^a   Carrero, Juan Jesús ^a   Qureshi, Abdul R ^a   Suliman, Mohamed E ^a   Heimbürger, Olof ^a   Bárány, Peter ^a   Lindholm, Bengt ^a   Alvestrand, Anders ^a   Schalling, Martin ^a   Nordfors, Louise ^a   Stenvinkel, Peter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

adipokines; cytokines; End stage renal disease (ESRD); fat mass

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; HEMOGLOBIN A1C; INTERLEUKIN 6; SERUM ALBUMIN; VASCULAR CELL ADHESION MOLECULE 1; VISFATIN;

ADIPOCYTE; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOTHELIUM LESION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; SURVIVAL;

ADIPOSE TISSUE; ADULT; AGED; BODY COMPOSITION; CYTOKINES; FEMALE; GENOTYPE; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33846630857     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.11.021     Document Type: Article

References (23)

1. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., Kilpatrick R.D., and Horwich T.B. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81 (2005) 543-554
2. Axelsson J., Heimburger O., Lindholm B., and Stenvinkel P. Adipose tissue and its relation to inflammation: The role of adipokines. J Ren Nutr 15 (2005) 131-136
3. Axelsson J., Qureshi A.R., Suliman M.E., et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80 (2004) 1222-1229
4. Stenvinkel P., Heimbürger O., and Lönnqvist F. Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant 12 (1997) 1321-1325
5. Stenvinkel P., Marchlewska A., Pecoits-Filho R., et al. Adiponectin in renal disease: Relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 65 (2004) 274-281
6. Fukuhara A., Matsuda M., Nishizawa M., et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 307 (2005) 426-430
7. Shinohara K., Shoji T., Emoto M., et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 1894-1900
8. Stenvinkel P., Heimbürger O., Paultre F., et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55 (1999) 1899-1911
9. Axelsson J., Bergsten A., Qureshi A.R., et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 69 (2006) 596-604
10. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 39:S1-S266 (suppl 1)
11. Cooper B.A., Bartlett L.H., Aslani A., Allen B.J., Ibels L.S., and Pollock C.A. Validity of Subjective Global Assessment as a nutritional marker in end-stage renal disease. Am J Kidney Dis 40 (2002) 126-132
12. Detsky A.S., McLaughlin J.R., Baker J.P., et al. What is Subjective Global Assessment of nutritional status?. J Parenter Enteral Nutr 33 (1987) 650-653
13. Kerr P.G., Strauss B.J.G., and Atkins R.C. Assessment of the nutritional state of dialysis patients. Blood Purif 14 (1996) 382-387
14. Ye S.Q., Zhang L.Q., Adyshev D., et al. Pre-B-cell-colony-enhancing factor is critically involved in thrombin-induced lung endothelial cell barrier dysregulation. Microvasc Res 70 (2005) 142-151
15. Nordfors L., Jansson M., and Sandberg G. Large-scale genotyping of single nucleotide polymorphisms by Pyrosequencing™ and validation against the 5′ nuclease (Taqman®) assay. Hum Mutat 19 (2002) 395-401
16. Kloting N., and Kloting I. Visfatin: Gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 332 (2005) 1070-1072
17. Stenvinkel P., Lindholm B., Heimburger M., and Heimburger O. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 15 (2000) 1624-1630
18. O'Byrne D., Devaraj S., Islam K.N., et al. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy. Metabolism 50 (2001) 207-215
19. Kralisch S., Klein J., Lossner U., et al. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 289 (2005) E586-E590
20. Curat C.A., Wegner V., Sengenes C., et al. Macrophages in human visceral adipose tissue: Increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49 (2006) 744-747
21. Berndt J., Kloting N., Kralisch S., et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54 (2005) 2911-2916
22. Samal B., Sun Y., Stearns G., Xie C., Suggs S., and McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14 (1994) 1431-1437
23. Ognjanovic S., Bao S., Yamamoto S.Y., Garibay-Tupas J., Samal B., and Bryant-Greenwood G.D. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 26 (2001) 107-117